申请人:Instituto Luso Farmaco d'Italia S.p.A.
公开号:US04235904A1
公开(公告)日:1980-11-25
The invention provides novel 4-aryl-5-aminoalkyl-1,3-dioxol-2-ones having hypocholesterolemic, hypolipemic, antiulcer, antihistaminic and antiserotoninic activities.
这项发明提供了新型的4-芳基-5-氨基烷基-1,3-二氧杂环戊烷-2-酮,具有降低胆固醇、降低脂质、抗溃疡、抗组胺和抗血清素活性。